Jiyan Biotech provides customers with professional organoid construction and identification services. The organoid construction process includes services such as clinical sampling, quality inspection, construction, and identification, etc.

Jiyan Biotech's service cases cover the evaluation of targeted drugs for drug - resistant lung cancer, ADC drugs for breast cancer, clinical drugs for colorectal cancer, gastric cancer, ovarian cancer, endometrial cancer, pancreatic cancer, liver cancer, etc.

Organoid - related Enteritis Modeling Research Services mainly include organoid structural morphology detection services and inflammatory - related factor detection services. In addition to enteritis modeling research services, Jiyan Biotech provides other inflammatory modeling research services, such as gastritis, pneumonia, hepatitis, etc.

Jiyan Biotech's organoid-related gut microbiota research services include fecal water co-culture services, probiotic co-culture services, etc. By using the BMEC biomimetic barrier chip to simulate the gut microbiota microenvironment and the intestinal organ chip, applied research such as the intestinal absorption of food and drugs, and the protective effects of probiotics can be simulated.

Jiyan Biotech offers organoid-related fatty liver modeling research services. The identification of lipid droplets in non - alcoholic fatty liver organoids includes Nile Red identification, Oil Red O identification, and triglyceride detection. Meanwhile, Jiyan Biotech provides kits for constructing fatty liver cell models, Oil Red O staining kits, and Nile Red fluorescence detection kits.

Jiyan Biotech provides organoid-related clinical drug evaluation services for endometriosis, as well as organoid growth status detection and organoid cell viability detection.

Jiyan Biotech offers comprehensive organ-chip customization services, covering the fields of basic scientific research and new drug development. For basic scientific research, we provide chip design, experimental testing, and manufacturing. For new drug development, we create animal-independent in vitro evaluation models.